Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Daiichi Sankyo
UBS
Accenture
Boehringer Ingelheim
Express Scripts
Cantor Fitzgerald
Harvard Business School
Federal Trade Commission

Generated: June 22, 2018

DrugPatentWatch Database Preview

DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Dextrose 4% In Modified Lactated Ringer's In Plastic Container, and what generic alternatives are available?

Dextrose 4% In Modified Lactated Ringer's In Plastic Container is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER is calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate. There are two hundred and seventy-five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate profile page.
Summary for DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER
Drug patent expirations by year for DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER

US Patents and Regulatory Information for DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate INJECTABLE;INJECTION 019634-002 Feb 24, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Queensland Health
Fuji
Daiichi Sankyo
Johnson and Johnson
Teva
US Department of Justice
Chinese Patent Office
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.